Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA4 | P22748 | 2/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.31 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20853606 | 0.82 | CES2 (0.32) | CES2CES1HTT | |
| SCHEMBL8175703 | 0.74 | CES2 (0.68) | CES2CES1HTTLMNATP53 | |
| SCHEMBL661258 | 0.74 | CES2 (0.46) | CES2CES1HTTLMNATP53 | |
| SCHEMBL4623333 | 0.73 | CES2 (0.52) | CES2CES1HTTLMNATP53 | |
| SCHEMBL317184 | 0.71 | CES2 (0.43) | CES2CES1HTTLMNATP53 | |
| SCHEMBL6448128 | 0.71 | CES2 (0.43) | CES2CES1HTTLMNATP53 | |
| SCHEMBL29449985 | 0.71 | CES2 (0.43) | CES2CES1HTTLMNATP53 | |
| SCHEMBL203915 | 0.71 | CES2 (0.43) | CES2CES1HTTLMNATP53 | |
| SCHEMBL336394 | 0.71 | CES2 (0.43) | CES2CES1HTTLMNATP53 | |
| SCHEMBL4962392 | 0.69 | CES2 (0.42) | CES2CES1HTTLMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 538 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8993754-B2 | Iridium complex and light emitting material formed from same | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2015-03-31 | — | — | US | claimed |
| US-12012426-B2 | Tetradentate diaminodiphosphine ligand and transition metal complex, and method for manufacturing same and application for same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2024-06-18 | — | — | US | disclosed |
| US-20240091228-A1 | Uridine Phosphorylase Inhibitors to Prevent or Treat Drug-Induced Pulmonary Dysfunction | TOSK, INC. | 2024-03-21 | — | — | US | disclosed |
| CN-117597139-A | Uridine phosphorylase inhibitors for preventing or treating drug-induced pulmonary dysfunction | 托斯克公司 | 2024-02-23 | — | — | CN | disclosed |
| CN-117581124-A | Resin film for polarizing plate, method for producing same, polarizing plate, and display device | 柯尼卡美能达株式会社 | 2024-02-20 | — | — | CN | disclosed |
| EP-4301398-A1 | URIDINE PHOSPHORYLASE INHIBITORS TO PREVENT OR TREAT DRUG-INDUCED PULMONARY DYSFUNCTION | Tosk, Inc. (US) | 2024-01-10 | — | — | EP | disclosed |
| US-20230405155-A1 | NANOPARTICLE, PHOTOACOUSTIC CONTRAST AGENT, PHOTODYNAMIC THERAPY DRUG, AND PHOTOTHERMAL THERAPY DRUG | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-12-21 | — | — | US | disclosed |
| EP-4241846-A1 | NANOPARTICLES, PHOTOACOUSTIC CONTRAST AGENT, PHOTODYNAMIC THERAPEUTIC AGENT, AND PHOTOTHERMAL THERAPEUTIC AGENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-09-13 | — | — | EP | disclosed |
| US-20230255971-A1 | Uridine Phosphorylase (UPase) Inhibitors for Treatment of Liver Conditions | TOSK, INC. | 2023-08-17 | — | — | US | disclosed |
| US-20230219983-A1 | TETRADENTATE DIAMINODIPHOSPHINE LIGAND AND TRANSITION METAL COMPLEX, AND METHOD FOR MANUFACTURING SAME AND APPLICATION FOR SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2023-07-13 | — | — | US | disclosed |
| EP-1117004-A2 | Electron beam or x-ray negative-working resist composition | FUJI PHOTO FILM CO., LTD. (JP) | 2001-07-18 | — | — | EP | disclosed |
| EP-1109066-A1 | Chemical amplification type negative-working resist composition for electron beams or x-rays | FUJI PHOTO FILM CO., LTD. (JP) | 2001-06-20 | — | — | EP | disclosed |
| US-6204390-B1 | REACTING A AROMATIC AMIDE COMPOUND WITH A OXAZOLIDIN-2,4-DIONE COMPOUND | KONICA CORPORATION (JP) | 2001-03-20 | — | — | US | disclosed |
| EP-1076261-A1 | Negative resist composition | FUJI PHOTO FILM CO., LTD. (JP) | 2001-02-14 | — | — | EP | disclosed |
| US-6027867-A | HAVING IMPROVED YELLOW COUPLER MOIETY CAPABLE OF COUPLING REACTION WITH AN OXIDATION PRODUCT OF A COLOR DEVELOPING AGENT AND BEING BONDED THROUGH A TRIAZOLE TO AN A-THIOCARBOXYLIC ESTER GROUP; STORAGE STABILITY | KONICA CORPORATION (JP) | 2000-02-22 | — | — | US | disclosed |
| EP-0976740-A1 | A synthesizing method for a 3-substituted-3-OXO-2-(2,4- Oxazolidinedion-3-YL)propionic acid amide compound | KONICA CORPORATION (JP) | 2000-02-02 | — | — | EP | disclosed |
| US-5556740-A | DIFFUSION TRANSFER PROCESS FOR SUPPORT WITH MULTILAYER HYDROPHILIC BINDER WITH SILVER HALIDE AND DYE | KONICA CORPORATION (JP) | 1996-09-17 | — | — | US | disclosed |
| EP-0656562-A2 | Diffusion transfer heat processable photosensitive material | KONICA CORPORATION (JP) | 1995-06-07 | — | — | EP | disclosed |
| US-5336593-A | With pyrazolotriazole magenta couplers, for image durability, lightfastness, efficient color formation, color reproduction | KONICA CORPORATION (JP) | 1994-08-09 | — | — | US | disclosed |
| EP-0379174-A2 | 2,3-Dihydro-3,3-dimethyl-5-trifluoromethanesulfonyloxybenzofurans, process for producing them and herbicides containing them | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1990-07-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230405155-A1 | NANOPARTICLE, PHOTOACOUSTIC CONTRAST AGENT, PHOTODYNAMIC THERAPY DRUG, AND PHOTOTHERMAL THERAPY DRUG | CRY2, RB1, NR2E3 | CES2 1904/4885CES1 3223/4885HTT 1895/4885 |
| US-20230219983-A1 | TETRADENTATE DIAMINODIPHOSPHINE LIGAND AND TRANSITION METAL COMPLEX, AND METHOD FOR MANUFACTURING SAME AND APPLICATION FOR SAME | ADH4, ADH5, PF4 | CES2 2676/4885CES1 3668/4885HTT 652/4885 |
| US-12012426-B2 | Tetradentate diaminodiphosphine ligand and transition metal complex, and method for manufacturing same and application for same | ADH4, ADH5, PF4 | CES2 2676/4885CES1 3668/4885HTT 652/4885 |
| US-20230255971-A1 | Uridine Phosphorylase (UPase) Inhibitors for Treatment of Liver Conditions | UMPS, UPP1, PNP | CES2 342/4885CES1 50/4885HTT 2944/4885 |
| US-20240091228-A1 | Uridine Phosphorylase Inhibitors to Prevent or Treat Drug-Induced Pulmonary Dysfunction | UMPS, UPP1, PNP | CES2 938/4885CES1 456/4885HTT 4397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.